Ozempic® Lawsuit

What is Ozempic?

Ozempic是诺和诺德公司生产的一种semaglutide笔式注射器的品牌名称. Semaglutide 药物会增加胰岛素的释放，对糖尿病的控制和减肥很有用. Other notable semaglutide drugs include Rybelsus® and Wegovy.

Ozempic is approved by the U.S. 美国食品和药物管理局(FDA)降低血糖水平，降低心脏病发作的风险, stroke, or death in adults with Type 2 diabetes.

Ozempic属于一类被称为GLP-1受体激动剂(GLP-1 RA)的药物。. 这些糖尿病药物使用的肽可以模拟澳门皇冠现金手机入口体内的天然饱腹激素. Semaglutide是这些肽中的一种，尽管其他GLP-1 RAs可能使用不同的肽.

By mimicking satiety hormones, 这种药物可以针对大脑中控制食欲和食物摄入的区域. This allows the drug to moderate insulin release and appetite. 

According to the FDA, 药物剂量必须每周逐渐增加，以减少胃肠道副作用. 患者需要长期服用这种药物，否则研究表明他们的体重会反弹. According to some research, 长期服药可能会增加副作用的风险.

Ozempic for weight loss: off-label use background

Ozempic也在标签外作为减肥药使用. Off-label use of drugs is both common and legal. 它允许医生使用他们的判断来治疗各种疾病，并可以扩大某些药物的效用. 

Soon after Ozempic hit the market in 2017, 临床医生观察到食欲抑制是副作用，体重经常下降. Novo Nordisk then developed Wegovy, a higher-dose version of Ozempic, to treat weight gain and obesity. 从那时起，这两种药物在减肥方面的受欢迎程度激增，导致了全国范围内的短缺. Ozempic revenue is projected to reach $12.5 billion in 2023.

While Ozempic has proven to work as an off-label weight loss aid, patients have reported unexpected and serious side effects, such as intestinal blockages and stomach paralysis or gastroparesis.

Health issues related to Ozempic

FDA目前正在调查通过其FDA不良事件报告系统(FAERS)提交的这些健康问题报告。. FAERS允许人们直接向该机构报告产品问题. A recent FAERS report shows the FDA is investigating several GLP-1 RA drugs, including Ozempic, for potentially causing intestinal obstructions. FDA于2023年9月更新了Ozempic的警告标签，包括潜在的肠道阻塞. 

In addition to consumer reports, studies are starting to link semaglutide drugs to serious health issues. 

A May 2023 letter to the editor 在研究期刊《澳门皇冠现金手机入口》(APSB)上讨论了这些问题. The letter authors urged clinicians to be aware of the adverse effects of drugs like Ozempic on the small intestine.

According to the letter, 到目前为止，由于试验持续时间不够长，在临床环境中对其影响的研究还不够充分. 

作者发现，肠梗阻发生率较高.6 years after GLP-1 RA treatments, 但大多数GLP-1类风湿性关节炎的临床试验持续时间不超过一年.  They also cited a study of more than 25,000 subjects that found a 3.服用GLP-1类RA药物的患者肠梗阻发生率增加5倍.

其他研究也将Ozempic与肠道阻塞联系起来 gallbladder disease. Intestinal blockage signs and symptoms may include: 

• Abdominal cramps and swelling
• Constipation
• Trouble having a bowel movement or passing gas
• Vomiting

医生最近也报告了胃麻痹的病人，也被称为 gastroparesis. 胃麻痹会阻止胃的神经和肌肉正常工作，导致食物在胃里停留的时间过长. This is called delayed gastric emptying. Common symptoms of gastroparesis include: 

• Abdominal bloating
• Abdominal pain
• Acid reflux
• Blood sugar fluctuation
• Constipation
• Feeling full very quickly    
• Indigestion
• Loss of appetite
• Malnutrition
• Nausea
• Upper abdominal pain
• Vomiting

Contact us

Complete this webform or call 1.800.768.4026 to contact attorney Sara Couch for more information or to discuss a potential Ozempic claim.

任何服用Ozempic(或任何其他GLP-1 RA)的患者，如果出现这些症状，应立即与医生交谈.

What are the Ozempic lawsuits about?

Wegovy and Ozempic lawsuits are still in the beginning stages. So far, 这些诉讼是由服用Ozempic的患者提起的，他们经历了药物警告标签上没有包括的严重副作用. 2023年9月，澳门皇冠现金手机入口的律师为宾夕法尼亚州的一名妇女提起诉讼，她在服用维格威后出现了严重的胃肠问题并住院治疗. Learn more about the case here. 

Ozempic和其他类似药物的制造商也起诉了其他制药公司，因为他们生产非品牌药品. 而消费者可能并不关心诺和诺德(Novo Nordisk)或礼来(Eli Lilly)等制药巨头的财务影响, they should be wary of the health impacts of these knockoff drugs.

这些高度公开的诉讼可能会为其他受到Ozempic伤害的人打开大门, Wegovy and similar drugs. 如果你或你所爱的人被奥兹匹克(或任何其他糖尿病药物)伤害，你可能有一个病例. Connect with an attorney to determine your eligibility for an Ozempic lawsuit.

Our medical drug litigation experience

澳门皇冠现金手机入口的医疗律师已经代理了数千名因危险的处方药和非处方药而严重受伤的患者. We understand that as a patient or family member, 你对你或你所爱的人的药物的了解可能是有限的. 

If you believe a medicine made you sick or hurt you, 澳门皇冠现金手机入口的律师拥有彻底调查所需的资源，并:

• Identify potentially harmful medicines
• Review if the medicine hurt you
• Review the medicine manufacturer’s compliance with FDA regulations
• 检查制造商对潜在副作用的警告是否充分
• Recognize other issues that could affect your potential claim

Learn more about our medical drug experience here.

没有咨询医生就停止服用处方药. 在没有医生建议的情况下停止服用处方药可能会导致受伤或死亡.